Selank and Semax: Nootropic Peptide Research

Introduction to Nootropic Peptide Research

Selank and Semax are synthetic peptides developed at the Institute of Molecular Genetics of the Russian Academy of Sciences during the 1980s and 1990s. Both are derived from naturally occurring endogenous molecules and have been the subject of extensive research in Russian and international scientific literature. They represent a unique class of research compounds — peptides designed to modulate cognitive function, neuroprotection, and emotional regulation through distinct molecular mechanisms.

Selank: Derived from Tuftsin

Selank (Thr-Lys-Pro-Arg-Pro-Gly-Pro) is a synthetic heptapeptide based on the immunomodulatory peptide tuftsin (Thr-Lys-Pro-Arg), which is a naturally occurring fragment of IgG immunoglobulin. Selank extends the tuftsin sequence with a Pro-Gly-Pro tripeptide tail that confers enzymatic resistance and enhances its neurotropic properties.

Research on Selank has primarily focused on anxiolytic and cognitive effects. Studies published in Russian pharmacology journals and in Bulletin of Experimental Biology and Medicine have documented effects on GABAergic signaling — specifically, Selank appears to modulate GABA-A receptor sensitivity and influence the balance between excitatory and inhibitory neurotransmission. This mechanism is distinct from benzodiazepines, which directly bind to the GABA-A receptor's allosteric site.

Gene expression studies have shown that Selank influences the expression of 36 genes related to neurotransmitter signaling, including genes involved in GABA, serotonin, and dopamine pathways. Research has also documented effects on brain-derived neurotrophic factor (BDNF) expression, suggesting a role in synaptic plasticity and neuronal survival beyond its immediate anxiolytic effects.

Selank: Immunomodulatory Research

Given its origin from tuftsin (an immune-modulating peptide), Selank has also been studied for immune effects. Research has demonstrated modulation of cytokine expression, effects on T-helper cell balance (Th1/Th2), and influence on immunoglobulin levels. This dual neuroimmune research profile — combining cognitive and immune research in a single peptide — distinguishes Selank from purely neurotropic compounds.

Semax: Derived from ACTH

Semax (Met-Glu-His-Phe-Pro-Gly-Pro) is a synthetic heptapeptide based on the 4-10 fragment of adrenocorticotropic hormone (ACTH). Like Selank, it incorporates a Pro-Gly-Pro C-terminal extension for enzymatic stability. Critically, Semax retains the neurotropic properties of the ACTH 4-10 fragment without the adrenal-stimulating (corticotropic) effects of full-length ACTH.

Research on Semax has focused heavily on neuroprotective and cognitive-enhancing effects. Studies published in Neuroscience and Behavioral Physiology and Doklady Biological Sciences have documented effects on attention, memory formation, and learning processes in preclinical models. Mechanistically, Semax research has identified effects on BDNF and nerve growth factor (NGF) expression, monoamine neurotransmitter systems (dopamine, serotonin, norepinephrine), and cerebrovascular dynamics.

Semax: Neuroprotective Research

Semax has been investigated in ischemic brain injury models, where research has demonstrated protective effects on neuronal survival and functional recovery. Studies show modulation of oxidative stress markers, reduced excitotoxic damage (via effects on glutamate signaling), and enhanced neuroplasticity in post-injury recovery phases. Research published in Russian neuroscience journals has documented effects on gene expression patterns associated with neuroprotection and neural regeneration.

Comparative Pharmacology

While both Selank and Semax are classified as nootropic peptides, they operate through distinct mechanisms and produce different research profiles. Selank's effects are primarily anxiolytic and GABAergic, with secondary cognitive and immunomodulatory properties. Semax's effects are primarily cognitive and neuroprotective, with prominent BDNF/NGF modulation and monoamine system involvement. Researchers studying nootropic peptides often investigate both compounds to understand how different neuropeptide pathways contribute to cognitive function.

Research Handling

Both Selank and Semax are supplied as lyophilized powder. They are relatively stable compared to larger peptides but should still be stored at -20°C for long-term use and 2-8°C for short-term storage. Reconstituted solutions should be used within 30 days. For research use only.

FAQ

What are Selank and Semax derived from?

Selank is derived from tuftsin, a naturally occurring immunomodulatory tetrapeptide fragment of IgG. Semax is derived from the 4-10 fragment of ACTH (adrenocorticotropic hormone). Both are extended with a Pro-Gly-Pro tripeptide for enzymatic stability.

How do Selank and Semax differ in their research profiles?

Selank is primarily studied for anxiolytic effects via GABAergic modulation, with secondary cognitive and immunomodulatory properties. Semax is primarily studied for cognitive enhancement and neuroprotection via BDNF/NGF modulation and monoamine system effects.

Does Semax have cortisol-stimulating effects like ACTH?

No. Semax is based on the ACTH 4-10 fragment, which retains the neurotropic properties of ACTH without the corticotropic (adrenal-stimulating) effects. Research has confirmed that Semax does not significantly elevate cortisol at research doses.